Drug Discovery Today
AUGUST 31, 2022
In the lead up to the inaugural launch of Connect In Pharma, co-founder Wilfried Phipps provides insight into what visitors can expect at this new annual event designed to help shape the future of pharmaceutical packaging and manufacturing projects
Antidote
AUGUST 29, 2022
In the world of medical research, experts are constantly looking for new drugs, treatments, and therapies for a variety of conditions — but the process of getting these treatments approved is only possible if they are tested through clinical trials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
AUGUST 27, 2022
This chart shows the pharmaceutical companies with the most spray dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most spray dosed drugs…. The post Which pharmaceutical companies have the most spray dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.
EG Life Sciences
SEPTEMBER 1, 2022
Introduction As we shared in Part 1 , the future of Pharma and Biotech is possible because of new tools and technologies, along with all clinical discoveries and relevant data that has accumulated throughout the years. In that blog, we learned about the technology drivers behind the Biotech processes and the collaborative strategies accelerating changes, facilitating dynamic response and the globalization of markets.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Advarra
AUGUST 31, 2022
Institutional biosafety committees (IBCs) frequently receive questions about the proper methodology for preparing a syringe for transport from a drug room or pharmacy to the clinic where the injection will be administered. This article explores tools and techniques to safely mitigate occupational exposure risks when preparing a syringe for transport to the clinic.
Antidote
AUGUST 31, 2022
When creating a clinical trial protocol, it’s important for sponsors to consider how each requirement impacts the patients who are taking part. While participating in a clinical trial can be beneficial for many reasons, it can also place a burden on patients who choose to participate. Complications with scheduling, transportation, and instructions can all create friction for patients — and can ultimately lead to dropouts if they are not addressed.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Pharma Manufacturing
AUGUST 29, 2022
Ethan Smith, general manager, Life Sciences at Nuvolo discusses how furthering pharma’s digitalization journey can help the industry reap big benefits in quality and manufacturing.
Advarra
AUGUST 31, 2022
In response to a growing demand for faster, approved, and cost-effective medical devices for chronic diseases, medical device manufacturers and emerging biotech companies are facing increasingly complex pathways to successfully bring their innovative ideas to the market. If a new medical device, software as a medical device (SaMD), or in vitro diagnostic (IVD) is poised to successfully make it through the development process to commercialization, sponsors must consider a trifecta of interconnect
LifeSciVC
AUGUST 30, 2022
By Peter Smith, co-founder and CEO, Remix Therapeutics, as part of the From The Trenches feature of LifeSciVC One of the joys of starting a company is the ability to pro-actively define the early corporate culture and encourage its evolution over time. When I think about what culture means and how to define it, it’s quickly apparent that what I think doesn’t matter.
Drug Patent Watch
SEPTEMBER 2, 2022
Annual Drug Patent Expirations for FINTEPLA Fintepla is a drug marketed by Zogenix Inc and is included in one NDA. It is available from one supplier. There are eleven patents…. The post New patent for Zogenix Inc drug FINTEPLA appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharma Manufacturing
SEPTEMBER 1, 2022
As patent barriers protecting the world's best-selling drug topple, biosimilars rush in
Drug & Device Law
AUGUST 30, 2022
Today’s post is actually about a medical malpractice case. But it involves the interplay between an FDA “Safety Communication” and punitive damages, so we thought it was worth looking at. In Rivera v. Valley Hospital, Inc. , 2022 WL 3650726 (NJ Aug. 25, 2022), plaintiff is the representative of the estate of a woman who passed away from leiomyosarcoma, a rare uterine cancer.
Drug Patent Watch
SEPTEMBER 2, 2022
Annual Drug Patent Expirations for EPIDIOLEX Epidiolex is a drug marketed by Gw Res Ltd and is included in one NDA. It is available from one supplier. There are twenty-two…. The post New patent for Gw Res drug EPIDIOLEX appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 2, 2022
Annual Drug Patent Expirations for MYFEMBREE Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. There are four patents protecting this drug. This drug has…. The post New patent for Myovant Sciences drug MYFEMBREE appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drug Patent Watch
AUGUST 31, 2022
This chart shows the pharmaceutical companies with the most patents in Bulgaria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Bulgaria? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
AUGUST 30, 2022
Annual Drug Patent Expirations for ABILIFY+MAINTENA+KIT Abilify Maintena Kit is a drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. It is available from one supplier.…. The post New patent for Otsuka Pharm drug ABILIFY MAINTENA KIT appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
AUGUST 29, 2022
This chart shows the drugs with the most patents in Ireland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Ireland? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
AUGUST 29, 2022
Annual Drug Patent Expirations for AMITIZA Amitiza is a drug marketed by Sucampo Pharma Llc and is included in one NDA. It is available from three suppliers. There are nine…. The post New patent expiration for Sucampo Pharma drug AMITIZA appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drug Patent Watch
AUGUST 28, 2022
This chart shows the pharmaceutical companies with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Croatia? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 2, 2022
Lisdexamfetamine dimesylate is the generic ingredient in one branded drug marketed by Takeda Pharms Usa and is included in two NDAs. There are nineteen patents protecting this compound. Drug patent…. The post New tentative approval for Amneal Pharms drug lisdexamfetamine dimesylate appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
AUGUST 31, 2022
Lisdexamfetamine dimesylate is the generic ingredient in one branded drug marketed by Takeda Pharms Usa and is included in two NDAs. There are nineteen patents protecting this compound. Drug patent…. The post New tentative approval for Amneal Pharms drug lisdexamfetamine dimesylate appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
AUGUST 30, 2022
This chart shows the drugs with the most patents in Switzerland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Switzerland? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
AUGUST 30, 2022
Lisdexamfetamine dimesylate is the generic ingredient in one branded drug marketed by Takeda Pharms Usa and is included in two NDAs. There are nineteen patents protecting this compound. Drug patent…. The post New tentative approval for Amneal Pharms drug lisdexamfetamine dimesylate appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
AUGUST 29, 2022
Lisdexamfetamine dimesylate is the generic ingredient in one branded drug marketed by Takeda Pharms Usa and is included in two NDAs. There are nineteen patents protecting this compound. Drug patent…. The post New tentative approval for Amneal Pharms drug lisdexamfetamine dimesylate appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
AUGUST 28, 2022
Lisdexamfetamine dimesylate is the generic ingredient in one branded drug marketed by Takeda Pharms Usa and is included in two NDAs. There are nineteen patents protecting this compound. Drug patent…. The post New tentative approval for Amneal Pharms drug lisdexamfetamine dimesylate appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
AUGUST 27, 2022
Lisdexamfetamine dimesylate is the generic ingredient in one branded drug marketed by Takeda Pharms Usa and is included in two NDAs. There are nineteen patents protecting this compound. Drug patent…. The post New tentative approval for Amneal Pharms drug lisdexamfetamine dimesylate appeared first on DrugPatentWatch - Make Better Decisions.
Drug & Device Law
SEPTEMBER 2, 2022
The puppies are here! We are delighted to follow up on our last post, wherein we announced that the mother of our standard-poodle-puppy-to-be was in the middle of giving birth. We are thrilled to report that the final tally includes eight beautiful, healthy pups – four boys and four girls, three white and five blue (a beautiful steel-gray color when mature, though blue puppies are born black).
Expert insights. Personalized for you.
113 
Let's personalize your content